tetrathiomolybdate inhibits copper trafficking proteins metal cluster formation
tetrathiomolybdate tm orally active agent treatment disorders copper metabolism describe tm inhibits proteins regulate copper physiology crystallographic results reveal surprising stability drug complex metallochaperone atx1 arises formation sulfur-bridged copper-molybdenum cluster reminiscent found molybdenum iron sulfur proteins spectroscopic studies indicate cluster stable solution corresponds physiological clusters isolated tm-treated wilsons disease animal models finally mechanistic studies show drug-metallochaperone inhibits metal transfer functions copper-trafficking proteins results consistent model wherein tm can directly reversibly down-regulate copper delivery secreted metalloenzymes suggest proteins involved metal regulation might fruitful drug targets
